The Motley Fool. DATE Wednesday, July 23, 2025, at 9:30 a.m. EDT CALL PARTICIPANTS Chief Executive Officer — Alok MaskaraChief Financial Officer — Michael Quenzer Need a quote from one of our analysts ...

Much of this transformation can be attributed to artificial intelligence (AI), which has steadily evolved from a futuristic ...

Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Commvault, a pioneering provider of cyber resilience and data protection solutions for the hybrid cloud, announced the ...

For Gundbert Scherf - the co-founder of Germany's Helsing, Europe's most valuable defence start-up - Russia's invasion of ...

Celsius's acquisition of Alani Nu is strategically sound, but integration and distribution execution risks remain. Read what ...

Quantum Computing is overvalued, unprofitable, and speculative. Read why we rate QUBT stock a strong sell and advise caution ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

Completed in 2003, the Human Genome Project gave us the first sequence of the human genome, albeit based on DNA from a small handful of people. Building upon its success, the 1000 Genomes Project was ...

The former partner at McKinsey & Company says Europe may be on the cusp of a transformation in defence innovation akin to the ...

The prevalence of allergic rhinitis (AR) varies between countries but is increasing globally as urbanisation and climate ...

A personalized naturopathic protocol resolved chronic migraines in a 46-year-old woman by targeting hormonal imbalance, gut ...